Free Newsletter
Antibody stimulates natural repair of MS damage
Low doses of a human antibody in mice were effective in repairing damaged myelin, a protective shield for nerves that is destroyed by multiple sclerosis. Scientists at the Mayo Clinic engineered an antibody--rHIgM22--so that it would bind to myelin and brain and spinal cord cells. That antibody triggered remyelination, restoring the protective sheath. This is the first known therapy that acts within the central nervous system. In addition, the scientists said that even at a very high dose, there were no recorded side effects from the treatment.
- here's the report from the Washington Post
Related Article:
Natural protein used to combat multiple sclerosis. Report
Comments
By Anonymous | Posted 2:16pm | December 15, 2009
Could this treatment not also be used to treat peripheral neuropathy?
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: